http://www.fpnotebook.com/
Nonsteroidal Anti-inflammatoryAka: Non-Steroidal Antiinflammatory, Non-Opioid Analgesics, NSAID
- See Also
- Mechanism
- Blocks Cyclooxygenase (COX)
- COX Enzyme converts arachidonic acid to PGG2
- COX1 Enzyme
- Location
- Gastric mucosa and intestinal mucosa
- Platelets
- Renal
- Vascular endothelium
- Inhibition Effects
- Predisposes to gastric or intestinal ulcers
- Predisposes to bleeding (anti-platelet adhesion)
- No anti-inflammatory effect
- Renal effects
- Fluid retention
- Decreased Glomerular Filtration Rate (GFR)
- Location
- COX2 Enzyme
- Location
- Brain
- Renal (ascending tubule, macula densa)
- Adenoma (colon)
- Cytokine-induced (inflammation related)
- Inhibition Effects
- Anti-inflammatory action
- Analgesic action
- Predisposes to renal injury in hypovolemia
- Decreased malignant potential of Colonic Polyps
- May have benefit in Alzheimer's Disease
- Location
- Adverse Effects
- NSAID Gastrointestinal Adverse Effects
- NSAID Renal Adverse Effects
- Bleeding risk
- Reversible inhibition of platelet aggregation
- Associated with standard NSAIDs (esp. Naprosyn)
- COX2 Inhibitors have minimal effect on bleeding
- Headache
- CNS effects (essp. Indomethacin)
- Interferes with Aspirin anti-platelet effects
- Monitoring protocol for NSAID use in elderly
- Labs: Obtain at baseline and q3-12 months
- Review of Systems for NSAID adverse effects
- References
- Non-Narcotic alternatives to NSAIDs
- Acetaminophen (Tylenol)
- Non-acetylated Salicylate
- Low dose Prednisone (Rheumatoid Arthritis)
- Single joint local Corticosteroid Injection
- Preparations: COX2 Selective NSAID
- Preparations: Acetic acids
- Partially COX2 selective (less GI adverse effects)
- Etodolac (Lodine) 200-400 mg PO bid-tid
- Etodolac 400 mg superior to Aspirin 650 mg
- Etodolac XL (Lodine XL) 400-1200 mg qd
- Nabumetone (Relafen) 1000 mg PO qd-bid
- Etodolac (Lodine) 200-400 mg PO bid-tid
- Indoles
- Indomethacin 25-50 mg PO/PR tid
- Sulindac (Clinoril) 150-200 mg PO bid
- Tolmetin sodium (Tolectin) 200-600 mg PO tid
- Pyrrolo-pyrroles: Parenteral NSAID
- Partially COX2 selective (less GI adverse effects)
- Preparations: Salicylates
- Acetylsalicylic acid (Aspirin) 500-1000 mg q4-6 hours
- TriSalicylate (Trilisate) 1000-1500 mg q8-12 hours
- Diflunisal (Dolobid) 500 mg q8-12 hours
- Superior and longer acting than Aspirin 650 mg
- Superior and longer acting than Acetaminophen 650 mg
- Salsalate (Disalcid)
- Sodium Salicylate (Uracil 5)
- Sodium thioSalicylate (Tusal)
- Preparations: Propionic Acids
- Ibuprofen (Motrin)
- Ibuprofen 400 mg comparable to Tylenol #3
- Naproxen (Naprosyn) 500 mg q12 hours
- Naproxen Sodium (Anaprox) 550 mg q12 hours
- Flurbiprofen (Ansaid) 200-300 mg/day divided bid-qid
- Fenoprofen (Nalfon) 200 mg q4-6 hours
- Similar to Aspirin
- Avoid in renal insufficiency
- Ketoprofen (Orudis) 25-75 mg q6-8 hours
- Ketoprofen 25 mg comparable to Ibuprofen 400 mg
- Ketoprofen 50 mg more potent than Tylenol #3
- Oxaprozin (Daypro) 1200 mg qd
- Ibuprofen (Motrin)
- Preparations: Oxicams
- General
- Long half life (once a day dosing)
- Isoxicam (Maxicam)
- Piroxicam (Feldene) 20 mg qd
- General
- Preparations: Fenamate
- References
- Wolfe (1999) N Engl J Med 340:1888
- (2000) Med Lett Drugs Ther 42(1085):73
- (2000) Tarascon Pocket Pharmacopoeia
